MoneyWorks4Me

The revenue for the September 2022 quarter is pegged at Rs. 9.29 millions against Rs. 0.00 millions recorded during the year-ago period.The Total Profit for the quarter ended September 2022 of Rs. 5.22 millions grew from Rs.-1.88 millionsOperating profit for the quarter ended September 2022 rose to 6.79 millions as compared to 0.09 millions of corresponding quarter ended September 2021.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202209 202109 % Var 202209 202109 % Var 202203 202103 % Var
Sales 9.29 0.00 0.00 21.21 0.00 0.00 1.27 0.00 0.00
Other Income 19.91 11.19 77.93 44.00 315.83 -86.07 395.35 296.13 33.51
PBIDT 6.79 0.09 7444.44 16.57 288.12 -94.25 339.68 -85.32 -498.12
Interest 0.08 0.34 -76.47 0.41 0.93 -55.91 2.47 5.58 -55.73
PBDT 6.71 -1.38 -586.23 15.73 136.06 -88.44 36.44 -90.90 -140.09
Depreciation 0.43 0.47 -8.51 0.85 0.95 -10.53 1.92 3.78 -49.21
PBT 6.28 -1.85 -439.46 14.88 135.11 -88.99 34.52 -94.68 -136.46
TAX 1.06 0.03 3433.33 1.11 -0.39 -384.62 4.96 -0.81 -712.35
Deferred Tax 1.06 0.03 3433.33 1.11 -0.39 -384.62 7.46 -2.91 -356.36
PAT 5.22 -1.88 -377.66 13.77 135.50 -89.84 29.56 -93.87 -131.49
Equity 766.33 766.33 0.00 766.33 766.33 0.00 766.33 766.33 0.00
PBIDTM(%) 73.09 0.00 0.00 78.12 0.00 0.00 26746.46 0.00 0.00
Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..